about
Interferon alpha versus any other drug for chronic hepatitis DHepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected HepatocyteQuantification of liver fibrosis in chronic hepatitis B virus infection.Prediction of fibrosis progression in chronic viral hepatitisHepatitis delta: epidemiology, diagnosis and management 36 years after discoveryPrevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: A single-center study.Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in ItalyG-quadruplexes in viruses: function and potential therapeutic applications.Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience.Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunityMolecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria.Prokaryotic Expression, Purification and Immunogenicity in Rabbits of the Small Antigen of Hepatitis Delta Virus.Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology.Discriminating Self and Non-Self by RNA: Roles for RNA Structure, Misfolding, and Modification in Regulating the Innate Immune Sensor PKRAnimal models of chronic hepatitis delta virus infection host-virus immunologic interactions.Hepatitis regulation by the inflammasome signaling pathway.Treatment of Delta Hepatitis: Today and in the Future - A review.Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification.Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova.Global strategies are required to cure and eliminate HBV infection.HDV infection rates in northern Vietnam.Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study.Anti-HDV seroprevalance among patients with previous HBV infection
P2860
Q24187640-319513CE-3170-4A0E-B7D0-CF4721776CD7Q26775635-A6AB0313-2909-461E-8762-5E274B52B7D9Q26782440-EBB7C9E9-0E03-4893-A27F-90B2F5416828Q26823671-7865673D-00BC-4936-9C92-3D2CF0231A7CQ26849602-B0A08A75-09D7-4352-AE6B-7BF546C6F03DQ33558023-0D4399D2-2AB2-49C1-97A7-AADD79BAB09CQ33796525-146996E6-5B4E-415F-9FAB-59F47FA55D69Q33801300-9F09FF89-C6C7-44F8-BF00-BECAAD0775E4Q34489819-B3066E14-7D37-4364-8897-DD40A3D13C47Q35267105-9E501749-133B-4AB1-A12C-5F817D35140AQ36053149-061F95F6-E936-4486-88A1-152B724D1964Q36765645-11BA48BC-2CAC-40A0-97C2-0A7888B0269CQ37377485-E91744DB-AB3C-4F95-A617-6F28435BD53CQ37444484-AC11523D-0A6F-457B-AAD5-1D4080D5687EQ37639170-8A6FAEC1-2D4C-4C25-9109-3A57300A856FQ38357110-E36B9C32-4FF8-4F06-B3CB-421BE2533DD5Q38423384-20B7563C-3A5D-4E04-B3D7-3E7DD885983CQ38769975-3B7C10B5-BBE8-4F94-B374-B30CBC4249BEQ40679543-6F0AE598-EB42-41F5-A1F1-BE8CE671C488Q42208612-40D20B58-FD8E-4ED2-9292-79F3182FF381Q43940290-9851CD24-9B9C-440B-91E0-130CBD616B87Q45325088-62CAAE29-8BEB-469C-8DC1-53D392473FADQ48860247-862E9C17-1236-48EF-9EEA-5B9730F7A775Q55119850-18479219-34A4-403D-B9D6-D2F2E50F8319Q55283042-0462C4C9-189F-4BBE-94A2-C3CB42AC06C2Q58131335-B8573D92-C1F3-46D7-826B-25D21549CBEF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An update on HDV: virology, pathogenesis and treatment.
@en
type
label
An update on HDV: virology, pathogenesis and treatment.
@en
prefLabel
An update on HDV: virology, pathogenesis and treatment.
@en
P2093
P356
P1433
P1476
An update on HDV: virology, pathogenesis and treatment
@en
P2093
Mario Rizzetto
Mónica V Alvarado-Mora
Stephen Locarnini
P304
P356
10.3851/IMP2598
P433
P50
P577
2013-06-21T00:00:00Z